VIVUS to Present at the Fourth Annual Robins Equity Research Round-Up
September 24 2018 - 7:30AM
VIVUS, Inc., (NASDAQ: VVUS), a biopharmaceutical company that
develops and commercializes novel therapeutic products to address
unmet medical needs in human health, announced today that it will
make a presentation at the Fourth Annual Robins Equity Research
Round-Up hosted by Catalyst Research Management Group in Portland,
Oregon.
The VIVUS, Inc. presentation will be made by CEO and Director
John Amos on Tuesday, September 25th at 11:00 a.m. Pacific Time.
The Robins Equity Research Round-Up is free to attend for brokers,
money managers and private investors.
About VIVUS
VIVUS is a biopharmaceutical company committed to the
development and commercialization of innovative therapies that
focus on advancing treatments for patients with serious unmet
medical needs. For more information about the Company, please visit
www.vivus.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking
within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements may be identified by the use of
forward-looking words such as "anticipate," "believe," "forecast,"
"estimate," "expect," "intend," "likely," "may," "plan,"
"potential," "predict," "opportunity" and "should," among others.
There are a number of factors that could cause actual events to
differ materially from those indicated by such forward-looking
statements. VIVUS does not undertake an obligation to update or
revise any forward-looking statements. Investors should read the
risk factors set forth in VIVUS' Form 10-K for the year ended
December 31, 2017 as filed on March 14, 2018, and as amended by the
Form 10-K/A filed on April 26, 2018, and periodic reports
filed with the Securities and Exchange Commission.
VIVUS, Inc. |
Investor Relations: Lazar Partners |
Mark Oki |
David Carey |
Chief Financial Officer |
Managing Director |
oki@vivus.com |
dcarey@lazarpartners.com |
650-934-5200 |
212-867-1768 |
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From Aug 2024 to Sep 2024
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From Sep 2023 to Sep 2024